Unknown

Dataset Information

0

Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: a propensity-score-weighted retrospective study.


ABSTRACT:

Background and aims

Innovative treatment modalities have not yet shown a clinical benefit in patients with septic shock. To reduce severe cytokinaemia, CytoSorb as an add-on to continuous renal replacement therapy (CRRT) showed promising results in case reports. However, there are no clinical trials investigating outcomes.

Methods

In this investigator-initiated retrospective study, patients with septic shock were treated with CRRT + CytoSorb (n?=?67) or CRRT alone (n?=?49). The primary outcome was the 28-day all-cause mortality rate. Patients were weighted by stabilized inverse probability of treatment weights (sIPTW) to overcome differences in baseline characteristics.

Results

At the start of therapy, CytoSorb-treated patients had higher lactate levels (p?ConclusionsCytoSorb was associated with a decreased observed versus expected 28-day all-cause mortality. By IPTW analysis, intervention with CytoSorb may be associated with a decreased all-cause mortality at 28?days compared to CRRT alone.

SUBMITTER: Brouwer WP 

PROVIDER: S-EPMC6749645 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: a propensity-score-weighted retrospective study.

Brouwer Willem Pieter WP   Duran Servet S   Kuijper Martijn M   Ince Can C  

Critical care (London, England) 20190918 1


<h4>Background and aims</h4>Innovative treatment modalities have not yet shown a clinical benefit in patients with septic shock. To reduce severe cytokinaemia, CytoSorb as an add-on to continuous renal replacement therapy (CRRT) showed promising results in case reports. However, there are no clinical trials investigating outcomes.<h4>Methods</h4>In this investigator-initiated retrospective study, patients with septic shock were treated with CRRT + CytoSorb (n = 67) or CRRT alone (n = 49). The pr  ...[more]

Similar Datasets

| S-EPMC10707447 | biostudies-literature
| S-EPMC8866295 | biostudies-literature
| S-EPMC8131695 | biostudies-literature
| S-EPMC7760738 | biostudies-literature
| S-EPMC8268021 | biostudies-literature
| S-EPMC9595535 | biostudies-literature
| S-EPMC8584981 | biostudies-literature
| S-EPMC8769135 | biostudies-literature
| S-EPMC9869834 | biostudies-literature
| S-EPMC10531588 | biostudies-literature